Real-time enrollment status for this refractory acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT06017258 |
| Recruiting Status | Recruiting |
| Condition | Refractory Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06017258 is currently recruiting participants. This clinical trial study for refractory acute myeloid leukemia is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06017258 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06017258 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.